In Brief: Nastech's Nascobal
Executive Summary
Nastech's Nascobal: Intranasal cyanocobalamin gel approved Nov. 5 for vitamin B-12 deficiency, including pernicious anemia, the Hauppage, N.Y. company announces Nov. 7. Nastech is seeking marketing partners for its inaugural approval. The company submitted the NDA Dec. 8, 1988. Nascobal will be available as a metered-dose gel in 5 mL bottles at a dosage strength of 500 mcg/.1 mL...